Cace Hurt
Payments from drug & device makers
Across 248 payments — averaging $13.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$482
- Novartis$412
- Novo Nordisk$336
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$299
- Bayer$270
- Boehringer Ingelheim$160
- plus $1K from 26 others
What the payments were for
- Food & beverage$3,336100%
- Education$30%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$3,339 in reported general payments places this provider in the 85th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nystatin | 15 | $476 |
| ProgesteroneProgesterone, Micronized | 13 | $266 |
| Levothyroxine Sodium | 35 | $233 |
| Metronidazole | 15 | $106 |
| Rosuvastatin Calcium | 11 | $72 |
Paid to pharmacies, not to this prescriber.
Other family in Tyler
- Machelle McDowellTyler$103K
- Jonathan KingTyler$97K
- Kirsten StuberTyler$79K
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
- Linda MercadoHouston$211K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.